← Back to headlines
BTIG Adjusts Humacyte (HUMA) Price Target While Maintaining Bullish Outlook
BTIG has lowered its price target for Humacyte (HUMA) but continues to hold a bullish view on the company's long-term opportunities.
29 Mar, 20:44 — 29 Mar, 20:44
Sources
Showing 1 of 1 sources
